Neurocrine Biosciences (NBIX) News Today $130.86 +1.98 (+1.53%) As of 02:29 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NBIX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Position Increased by Persistent Asset Partners LtdAugust 13 at 7:05 AM | marketbeat.comDeutsche Bank AG Sells 34,848 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)August 13 at 3:45 AM | marketbeat.comNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Director Kevin Charles Gorman Sells 106,322 SharesAugust 12 at 7:42 PM | marketbeat.comHeadlands Technologies LLC Sells 3,915 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)August 12 at 4:24 AM | marketbeat.comNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Holdings Lowered by Vanguard Group Inc.August 12 at 4:04 AM | marketbeat.comCetera Investment Advisers Acquires 3,688 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)August 12 at 3:18 AM | marketbeat.comASR Vermogensbeheer N.V. Invests $465,000 in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)August 11 at 4:43 AM | marketbeat.com6,241 Shares in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Acquired by Condor Capital ManagementAugust 10 at 6:49 AM | marketbeat.comCenterBook Partners LP Buys New Shares in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)August 9, 2025 | marketbeat.comMutual of America Capital Management LLC Has $5.68 Million Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)August 9, 2025 | marketbeat.comOntario Teachers Pension Plan Board Buys Shares of 15,379 Neurocrine Biosciences, Inc. (NASDAQ:NBIX)August 9, 2025 | marketbeat.comPrimecap Management Co. CA Has $42.30 Million Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)August 8, 2025 | marketbeat.comJefferies Financial Group Inc. Acquires Shares of 4,500 Neurocrine Biosciences, Inc. (NASDAQ:NBIX)August 7, 2025 | marketbeat.comNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Federated Hermes Inc.August 7, 2025 | marketbeat.comNeurocrine Biosciences to Present at the Canaccord Genuity 45th Annual Growth ConferenceAugust 6, 2025 | gurufocus.comNeurocrine Biosciences to Present at the Canaccord Genuity 45th Annual Growth ConferenceAugust 6, 2025 | prnewswire.comBrokerages Set Neurocrine Biosciences, Inc. (NASDAQ:NBIX) PT at $160.90August 6, 2025 | americanbankingnews.comHC Wainwright Issues Pessimistic Forecast for NBIX EarningsAugust 5, 2025 | americanbankingnews.comLeerink Partnrs Issues Positive Forecast for NBIX EarningsAugust 5, 2025 | americanbankingnews.comNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Holdings Boosted by Raiffeisen Bank International AGAugust 4, 2025 | marketbeat.comNBIX FY2026 EPS Forecast Increased by Cantor FitzgeraldAugust 4, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for NBIX FY2026 Earnings?August 4, 2025 | marketbeat.comWedbush Brokers Boost Earnings Estimates for NBIXAugust 4, 2025 | marketbeat.comWilliam Blair Has Bullish Estimate for NBIX Q3 EarningsAugust 4, 2025 | americanbankingnews.comLeerink Partnrs Has Bullish Forecast for NBIX Q3 EarningsAugust 4, 2025 | marketbeat.comWilliam Blair Analysts Increase Earnings Estimates for NBIXAugust 4, 2025 | marketbeat.comNeurocrine Biosciences’ Earnings Call Highlights GrowthAugust 3, 2025 | theglobeandmail.comNeurocrine Biosciences (NASDAQ:NBIX) Stock Rating Upgraded by Wall Street ZenAugust 3, 2025 | marketbeat.comCantor Fitzgerald Has Positive View of NBIX FY2025 EarningsAugust 3, 2025 | americanbankingnews.comNeurocrine Biosciences (NASDAQ:NBIX) Stock Price Expected to Rise, Guggenheim Analyst SaysAugust 2, 2025 | marketbeat.comCantor Fitzgerald Issues Positive Estimate for NBIX EarningsAugust 2, 2025 | marketbeat.comLindenwold Advisors INC Purchases Shares of 2,160 Neurocrine Biosciences, Inc. (NASDAQ:NBIX)August 2, 2025 | marketbeat.comNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Position Raised by Mackenzie Financial CorpAugust 2, 2025 | marketbeat.comJPMorgan Chase & Co. Forecasts Strong Price Appreciation for Neurocrine Biosciences (NASDAQ:NBIX) StockAugust 1, 2025 | marketbeat.comRoyal Bank Of Canada Cuts Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $144.00August 1, 2025 | marketbeat.comNeurocrine Biosciences Advances Schizophrenia Treatment with Phase 3 StudyAugust 1, 2025 | tipranks.comNeurocrine Biosciences (NASDAQ:NBIX) Price Target Raised to $174.00 at Stifel NicolausAugust 1, 2025 | marketbeat.comNeurocrine Biosciences (NASDAQ:NBIX) Given New $175.00 Price Target at Piper SandlerAugust 1, 2025 | marketbeat.comNeurocrine Biosciences (NASDAQ:NBIX) Price Target Raised to $141.00August 1, 2025 | marketbeat.comTredje AP fonden Has $4.10 Million Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)August 1, 2025 | marketbeat.comXTX Topco Ltd Buys 12,688 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)August 1, 2025 | marketbeat.comTD Asset Management Inc Raises Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)August 1, 2025 | marketbeat.comThe Analyst Verdict: Neurocrine Biosciences In The Eyes Of 17 ExpertsAugust 1, 2025 | benzinga.comNeurocrine (NBIX) Q2 Revenue Jumps 17%July 31, 2025 | fool.comZurcher Kantonalbank Zurich Cantonalbank Boosts Stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)July 31, 2025 | marketbeat.comNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Pacer Advisors Inc.July 31, 2025 | marketbeat.comAllianz Asset Management GmbH Decreases Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)July 31, 2025 | marketbeat.comNeurocrine Biosciences Inc (NBIX) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ...July 31, 2025 | gurufocus.comQ2 2025 Neurocrine Biosciences Inc Earnings Call TranscriptJuly 30, 2025 | gurufocus.comNeurocrine Biosciences (NBIX) Reports Strong Q2 2025 PerformanceJuly 30, 2025 | gurufocus.com Get Neurocrine Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NBIX and its competitors with MarketBeat's FREE daily newsletter. Email Address NBIX Media Mentions By Week NBIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NBIX News Sentiment▼1.190.73▲Average Medical News Sentiment NBIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NBIX Articles This Week▼1820▲NBIX Articles Average Week Get Neurocrine Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NBIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biogen News Today Incyte News Today United Therapeutics News Today BioMarin Pharmaceutical News Today Exelixis News Today Madrigal Pharmaceuticals News Today Halozyme Therapeutics News Today Exact Sciences News Today Ionis Pharmaceuticals News Today Repligen News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NBIX) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurocrine Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access